Risk assessment for biopharmaceutical single-use manufacturing: A case study of upstream continuous processing
{{output}}
In the current transition to intensified upstream processing, the risks of adopting traditional single-use systems for high-titer, long-duration perfusion cultures, have thus far not been considered. This case study uses the Failure Modes and Effects Analysis ... ...
